The genetic testing
industry, all in one place.

MENA nations are investing in homegrown genomic infrastructure to reduce dependence on Western datasets and drive regional precision medicine.

Gene Solutions is pursuing a Hong Kong IPO to accelerate its genomic testing expansion across Southeast Asia's fast-growing healthcare markets.

NeoGenomics launches its FDA-approved PTEN companion diagnostic test, prompting analysts to revisit whether NEO shares are underpriced.

Standard cancer genetic testing protocols may fail to detect the majority of inherited gene variants, raising urgent questions about clinical completeness.

Advanced DNA analysis has identified a homicide victim more than four decades after the 1983 crime, demonstrating forensic genomics' growing reach.

Arboretum launches to bring precision medicine's molecular depth to common diseases, positioning itself as a next-gen molecular information company.

New research into fetal DNA biology may sharpen the accuracy and reliability of non-invasive prenatal genetic testing.

Whole genome sequencing achieved a 47% diagnostic yield in pediatric neurological cases, signaling a paradigm shift in rare disease medicine.